Table 4.
Participant characteristics of both subgroups within the latent class analysis (p value was calculated based on the Wilcoxon test)
| Class 1 (n = 135; 59.7%) | Class 2 (n = 91; 40.3%) | p value | |
|---|---|---|---|
| Mean (SD) or n (%) | Mean (SD) or n (%) | ||
| Demographic characteristics | |||
| Age | |||
| Mean (SD) | 44.41 (10.58) | 48.58 (11.57) | 0.000 |
| Gender | |||
| Male | 117 (86.7) | 77 (84.6) | 0.045 |
| Female | 17 (12.6) | 14 (15.4) | |
| Diverse | 1 (0.7) | 0 (0.0) | |
| Educational attainment | |||
| Secondary general school or less | 15 (11.1) | 4 (4.4) | 0.000 |
| Intermediate secondary school | 43 (31.9) | 26 (28.6) | |
| (Technical) University entrance qualification | 75 (55.6) | 60 (65.9) | |
| Others | 2 (1.5) | 1 (1.1) | |
| Place of living | |||
| Large city/suburbs (100.000 inhabitants or more) | 101 (74.8) | 77 (84.6) | 0.000 |
| Middle-size city (20.000–100.000 inhabitants) | 12 (8.9) | 7 (7.7) | |
| Small city, village (<20,000 inhabitants) | 22 (16.3) | 7 (7.7) | |
| Sexual orientation | |||
| Heterosexual | 17 (12.6) | 12 (13.2) | 0.00 |
| Homosexual | 113 (83.7) | 71 (78.0) | |
| Other | 5 (3.7) | 8 (8.8) | |
| Health status | |||
| Good or better | 110 (81.5) | 69 (75.8) | 0.000 |
| Satisfactory | 21 (15.6) | 21 (23.1) | |
| Bad or worse | 4 (3.0) | 1 (1.1) | |
| Year of HIV diagnosis and first treatment | |||
| Year of HIV diagnosis (range) | 2007 (1985–2020) | 2005 (1984–2019) | 0.000 |
| Year of first treatment (range) | 2009 (1989–2020) | 2007 (1984–2019) | 0.000 |
| HIV treatment-related issues | |||
| Current HIV treatment | |||
| Pill-based | 129 (95.6) | 89 (97.8) | 0.000 |
| Injection-based | 6 (4.4) | 2 (2.2) | |
| Number of daily HIV-related pills (n = 218) | |||
| 1 | 103 (79.8) | 61 (68.5) | 0.000 |
| 2 | 13 (10.1) | 12 (13.5) | |
| 3+ | 12 (9.3) | 10 (9.6) | |
| Duration of current HIV therapy (months) | |||
| <6 | 5 (3.7) | 4 (4.4) | 0.000 |
| 6–12 | 13 (9.6) | 5 (5.5) | |
| 12+ | 117 (86.7) | 82 (90.1) | |
| Location of medical care | |||
| Inpatient-based (e.g., hospital) | 22 (16.3) | 10 (11.0) | 0.000 |
| Outpatient-based (e.g., specialized practice) | 113 (83.7) | 81 (89.0) | |
| Travel time to the location of medical care (minutes) | |||
| <30 | 87 (64.4) | 63 (69.2) | 0.000 |
| 30–60 | 27 (20.0) | 18 (19.8) | |
| 60+ | 21 (15.6) | 10 (11.0) | |
| Satisfaction with current HIV therapy | |||
| (Very) satisfied | 122 (90.4) | 84 (92.3) | 0.013 |
| More or less | 9 (6.7) | 5 (5.5) | |
| (Very) dissatisfied | 4 (3.0) | 2 (2.2) |
HIV human immunodeficiency virus, SD standard deviation